Patents by Inventor Betty P. Tsao

Betty P. Tsao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Genetic marker test for lupus
    Patent number: 7037651
    Abstract: Disclosed is a genetic testing method for diagnosing systemic lupus erythematosus (SLE) in a human subject. The method is related to amplifying nucleic acids from human tissue samples and detecting the presence or absence of variant alleles of a gene encoding poly(ADP-ribosyl)transferase expression (PARP), which are diagnostic of SLE or indicate a genetic predisposition for developing SLE. Also disclosed are useful oligonucleotide primers, primer sets and genetic testing kits for detecting a genetic predisposition for developing SLE.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: May 2, 2006
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Betty P. Tsao, Rita M. Cantor, Jerome I. Rotter
  • Genetic marker test for lupus
    Publication number: 20040152075
    Abstract: Disclosed is a genetic testing method for diagnosing systemic lupus erythematosus (SLE) in a human subject. The method is related to amplifying nucleic acids from human tissue samples and detecting the presence or absence of variant alleles of a gene encoding poly(ADP-ribosyl)transferase expression (PARP), which are diagnostic of SLE or indicate a genetic predisposition for developing SLE. Also disclosed are useful oligonucleotide primers, primer sets and genetic testing kits for detecting a genetic predisposition for developing SLE.
    Type: Application
    Filed: July 18, 2001
    Publication date: August 5, 2004
    Inventors: Betty P. Tsao, Rita M. Cantor, Jerome I. Rotter
  • Genetic marker test for lupus
    Patent number: 6280941
    Abstract: Disclosed is a genetic testing method for diagnosing systemic lupus erythematosus (SLE) in a human subject. The method is related to amplifying nucleic acids from human tissue samples and analyzing for a variant allele of a gene encoding poly(ADP-ribosyl)transferase expression (PARP), which is diagnostic of SLE or indicates a genetic predisposition for developing SLE. Also disclosed are useful oligonucleotide primers, primer sets and genetic testing kits for detecting a genetic predisposition for developing SLE.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: August 28, 2001
    Assignees: Cedars-Sinai Medical Center, The Regents of the University of California
    Inventors: Betty P. Tsao, Rita M. Cantor, Jerome I. Rotter